Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis: a comprehensive review for the physician assistant.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Structural connectomics in brain diseases.
Progressive multiple sclerosis and mood disorders.
Lipopolysaccharide Upregulates the Expression of CINC-3 and LIX in Primary NG2 Cells.
Afferent visual pathways in multiple sclerosis: a review.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Does multiple sclerosis affect glucose tolerance?
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.
Multiple sclerosis, solitary sclerosis or something else?
[Cost of multiple sclerosis in France.]
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Cervical Disk Pathology in Patients With Multiple Sclerosis: Two Case Reports.
Determinants of the severity of comorbid migraine in multiple sclerosis.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
Gait variability and disability in multiple sclerosis.
Multiple sclerosis and the spinal cord.
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
Natalizumab adverse events are rare in patients with multiple sclerosis.
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
Pages
« first
‹ previous
…
232
233
234
235
236
237
238
239
240
…
next ›
last »